Abstract
Previously, we have demonstrated, using several experimental models, the presence of a pronounced morphogenetic activity of total RNA preparations isolated from lymphoid cells of healthy young animals, as well as lymphocytes of human peripheral blood, and the adequacy of this activity to that of the lymphocytes themselves was proved. Based on the revealed properties of such preparations, we propose to use the total RNA obtained from lymphocytes at the earliest stage of the recovery process in vaccinology as a universal adjuvant that will accelerate the induction of the reactivity of the infected person’s lymphocytes and increase the level of their activity, and therefore, enhance the body’s defense function and increase the duration of the immunity produced.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
